PROSCA & BLADDR 2023

 

PROSCA & BLADDR 2023
Avatar

Perioperative Systemic Therapies for MIBC

By PROSCA & BLADDR 2023 FEATURING Bernadett Szabados
By PROSCA & BLADDR 2023 FEATURING Bernadett Szabados
113 views
January 18, 2024
0 Comments
Login to view comments. Click here to Login
BLADDR
07:53

Future Management of T2N0M0 Urothelial Carcinoma From the Urologist’…

PROSCA & BLADDR 2023

E. Laukhtina

164 views
08:01

Future Management of T2N0M0 Urothelial Carcinoma From the Medical On…

PROSCA & BLADDR 2023

D. Raggi

31 views
11:05

Future Management of T2N0M0 Urothelial Carcinoma From the Pathologis…

PROSCA & BLADDR 2023

A. Cimadamore

21 views
09:24

Future Management of T2N0M0 Urothelial Carcinoma From the Radiation …

PROSCA & BLADDR 2023

P. Sargos

20 views
06:04

Arguments for Using Urinary Biomarkers for the Surveillance of NMIBC

PROSCA & BLADDR 2023

F. Witjes

28 views
08:52

Urinary Biomarkers for the Surveillance of NMIBC: Why the Role of Cy…

PROSCA & BLADDR 2023

M. Moschini

44 views
09:57

Obstacles and Opportunities With Staging, Grading, and Molecular Cla…

PROSCA & BLADDR 2023

E. Comperat

20 views
11:34

Small Cell Neuroendocrine Carcinoma of the Urinary Bladder

PROSCA & BLADDR 2023

P. Hoskin

20 views
10:15

Management of Upper Urinary Tract Carcinoma In Situ

PROSCA & BLADDR 2023

B. Konety

50 views
09:41

Perioperative Systemic Therapies for MIBC

PROSCA & BLADDR 2023

B. Szabados

113 views
09:18

Best Practices for Radical Cystectomy and Urinary Reconstruction

PROSCA & BLADDR 2023

B. Konety

134 views
07:05

Novel Systemic Approaches Towards Bladder Preservation

PROSCA & BLADDR 2023

B. De Ruiter

24 views
11:41

The Role of RT in Bladder Preservation

PROSCA & BLADDR 2023

X. Maldonado

86 views
16:26

High-Risk, BCG-Unresponsive NMIBC Beyond Radical Cystectomy: Intrave…

PROSCA & BLADDR 2023

F. Guerrero-Ramos

85 views
08:08

Response to Bladder Cancer Treatment in Men and Women

PROSCA & BLADDR 2023

U. Vogl

29 views
06:44

Positive Surgical Margins After Radical Cystectomy for MIBC: What’s …

PROSCA & BLADDR 2023

P. Sargos

29 views
06:41

Handling High-Risk Localized UTUC: The Role of Perioperative Treatme…

PROSCA & BLADDR 2023

I. Durán

27 views
04:34

Risk Stratification in NMIBC

PROSCA & BLADDR 2023

F. Guerrero-Ramos

36 views
09:09

Improving the Quality of Tumor Resection in Bladder Cancer

PROSCA & BLADDR 2023

L. Mertens

16 views
10:21

High-Risk NMIBC Beyond Radical Cystectomy: The Role of RT

PROSCA & BLADDR 2023

V. Achard

57 views
12:09

Bladder Cancer Targeted Therapies on the Horizon: All Good or Should…

PROSCA & BLADDR 2023

P. Grivas

112 views
11:47

Dealing With Adverse Events of Targeted Therapies in Bladder Cancer

PROSCA & BLADDR 2023

R. Jones

49 views
09:30

A New SOC in 1L Treatment of mUC?

PROSCA & BLADDR 2023

I. Durán, D. Castellano

100 views
10:38

Best Practices for mUC: Defining & Treating Oligometastatic Bladder …

PROSCA & BLADDR 2023

P. Hoskin

95 views
10:37

Treatment Advancements for Intermediate-Risk NMIBC

PROSCA & BLADDR 2023

J. Irani

28 views
08:24

Health-Related QoL After TMT in Bladder Cancer: Translation Into Dai…

PROSCA & BLADDR 2023

D. Leelamany

25 views
11:03

Misconceptions About TMT in Bladder Cancer

PROSCA & BLADDR 2023

V. Fonteyne

44 views
11:56

mUC Data With an Impact on Clinical Practice

PROSCA & BLADDR 2023

D. De Maeseneer

101 views
12:50

NMIBC & MIBC Data With an Impact on Clinical Practice

PROSCA & BLADDR 2023

B. Szabados

97 views